Shields, B. M., Angwin, C. D., Shepherd, M. H., Britten, N., Jones, A. G., Sattar, N., . . . Hattersley, A. T. (2023). Patient preference for second and third line therapies in type 2 diabetes: A prespecified secondary endpoint of the TriMaster study. Nat Med.
Chicago Stili AlıntıShields, Beverley M., Catherine D. Angwin, Maggie H. Shepherd, Nicky Britten, Angus G. Jones, Naveed Sattar, Rury Holman, Ewan R. Pearson, ve Andrew T. Hattersley. "Patient Preference for Second and Third Line Therapies in Type 2 Diabetes: A Prespecified Secondary Endpoint of the TriMaster Study." Nat Med 2023.
MLA AlıntıShields, Beverley M., et al. "Patient Preference for Second and Third Line Therapies in Type 2 Diabetes: A Prespecified Secondary Endpoint of the TriMaster Study." Nat Med 2023.